These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction. Verboom CN; Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effects of omega-3 fatty acids. Reiffel JA; McDonald A Am J Cardiol; 2006 Aug; 98(4A):50i-60i. PubMed ID: 16919517 [TBL] [Abstract][Full Text] [Related]
4. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Marchioli R; Barzi F; Bomba E; Chieffo C; Di Gregorio D; Di Mascio R; Franzosi MG; Geraci E; Levantesi G; Maggioni AP; Mantini L; Marfisi RM; Mastrogiuseppe G; Mininni N; Nicolosi GL; Santini M; Schweiger C; Tavazzi L; Tognoni G; Tucci C; Valagussa F; Circulation; 2002 Apr; 105(16):1897-903. PubMed ID: 11997274 [TBL] [Abstract][Full Text] [Related]
6. A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Lamotte M; Annemans L; Kawalec P; Zoellner Y Pharmacoeconomics; 2006; 24(8):783-95. PubMed ID: 16898848 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Marchioli R; Schweiger C; Tavazzi L; Valagussa F Lipids; 2001; 36 Suppl():S119-26. PubMed ID: 11837985 [TBL] [Abstract][Full Text] [Related]
8. [The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]. Marchioli R; Di Pasquale A G Ital Cardiol; 1993 Sep; 23(9):933-64. PubMed ID: 8119523 [No Abstract] [Full Text] [Related]
9. n-3 PUFAs and cardiovascular disease prevention. Manerba A; Vizzardi E; Metra M; Dei Cas L Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340 [TBL] [Abstract][Full Text] [Related]
10. [Highly concentrated omega-3-fatty acids. A new means in the secondary prevention]. MMW Fortschr Med; 2005 Oct; 147(43):60-1. PubMed ID: 16302426 [No Abstract] [Full Text] [Related]
12. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial. Harris WS; Masson S; Barlera S; Milani V; Pileggi S; Franzosi MG; Marchioli R; Tognoni G; Tavazzi L; Latini R; Nutr Res; 2016 Sep; 36(9):989-994. PubMed ID: 27632919 [TBL] [Abstract][Full Text] [Related]
13. Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease. de Lorgeril M; Salen P J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S38-41. PubMed ID: 17876197 [TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmia effects of omega-3 fatty acids. A review]. De Caterina R; Madonna R Ital Heart J Suppl; 2002 Mar; 3(3):297-308. PubMed ID: 12040845 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial. Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F; J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722 [TBL] [Abstract][Full Text] [Related]
16. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. Rupp H Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial. Franzosi MG; Brunetti M; Marchioli R; Marfisi RM; Tognoni G; Valagussa F; Pharmacoeconomics; 2001; 19(4):411-20. PubMed ID: 11383757 [TBL] [Abstract][Full Text] [Related]
18. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet; 1999 Aug; 354(9177):447-55. PubMed ID: 10465168 [TBL] [Abstract][Full Text] [Related]
19. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Leaf A Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotection by omega-3 fatty acids: involvement of PKCs? Le Guennec JY; Jude S; Besson P; Martel E; Champeroux P Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):173-7. PubMed ID: 20189372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]